Carbonic Anhydrase XII/CA12 Antibody (08) [Janelia Fluor® 549], Novus Biologicals
Bio-Techne includes Novus Biologicals | Catalog # NBP3-26096JF549
Recombinant Monoclonal Antibody
Conjugate
Catalog #
Forumulation
Catalog #
Key Product Details
Species Reactivity
Validated:
Human
Applications
ELISA
Label
Janelia Fluor 549
Antibody Source
Recombinant Monoclonal Mouse IgG1 Clone # 08
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Summary for Carbonic Anhydrase XII/CA12 Antibody (08) [Janelia Fluor® 549]
Immunogen
This product is a recombinant monoclonal antibody expressed from HEK293 cells.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG1
Applications for Carbonic Anhydrase XII/CA12 Antibody (08) [Janelia Fluor® 549]
Application
Recommended Usage
ELISA
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: Carbonic Anhydrase XII/CA12
Alternate Names
CA12
Gene Symbol
CA12
Additional Carbonic Anhydrase XII/CA12 Products
Product Documents for Carbonic Anhydrase XII/CA12 Antibody (08) [Janelia Fluor® 549]
Product Specific Notices for Carbonic Anhydrase XII/CA12 Antibody (08) [Janelia Fluor® 549]
Sold under license from the Howard Hughes Medical Institute, Janelia Research Campus.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...